AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infectionArticle Published on 2023-01-172023-07-11 Journal: Cell Reports Medicine [Category] COVID19(2023년), [키워드] AZD1222 Breakthrough infection ChAdOx1 nCoV-19 COVID-19 vaccine immunoassay mucosal immune response Nasal antibody nasal mucosal immunity SARS-CoV-2 spike antibodies Serology. [DOI] 10.1016/j.xcrm.2022.100882 PMC 바로가기
Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infectionArticle Published on 2023-01-012023-07-10 Journal: Journal of medical virology [Category] COVID19(2023년), [키워드] assay sensitivity binding antibodies COVID-19 immunoassay neutralizing antibodies. omicron SARS-CoV-2 [DOI] 10.1002/jmv.28200 PMC 바로가기
Protein A-Nanoluciferase fusion protein for generalized, sensitive detection of immunoglobulin GArticle Published on 2023-01-012023-07-10 Journal: Analytical biochemistry [Category] COVID19(2023년), [키워드] bioluminescence IgG detection immunoassay nanoluciferase protein A SARS-CoV-2 nucleoprotein. [DOI] 10.1016/j.ab.2022.114929 PMC 바로가기
SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassaysArticle Published on 2022-12-012022-11-15 Journal: Diagnostic microbiology and infectious disease [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] anti-N antibody anti-RBD anti-S2 Anti-spike antibodies antibody Antibody profile Antigen average Cohort demonstrated exhibited HCW healthcare worker IgG immune immunoassay individual Infection infection cohort mRNA vaccines multiplex natural infection Patient positive produced reactivity SARS-CoV-2 SARS-CoV-2 antibody semi-quantitative Support target vaccinated individual vaccination vaccination. [DOI] 10.1016/j.diagmicrobio.2022.115803 PMC 바로가기
A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer responseArticle Published on 2022-12-012022-11-15 Journal: Analytical biochemistry [Category] COVID19(2023년), SARS, 진단, [키워드] Antibody titer chemiluminescent immunoassay CLIA CMIA Convalescent plasma therapy Coronavirus disease 2019 COVID-19 Efficacy effort ELISA human donor identify immune response Immune titer immunoassay Lateral LFIA pandemic plaque PRNT reactive SARS-CoV-2 serological serological test Serologist Serologist method serology test Test Vaccine vaccine. Vaccines [DOI] 10.1016/j.ab.2022.114902 PMC 바로가기
Ultrasensitive monitoring of SARS-CoV-2-specific antibody responses based on a digital approach reveals one week of IgG seroconversionArticle Published on 2022-12-012022-11-15 Journal: Biosensors & bioelectronics [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] addition antibodies Antibody Response approach AUC collected COVID-19 COVID-19 patient diagnostic diagnostics Donor Extreme early-stage seroconversion faster flow cytometry healthy IgG IgG and IgM IgG/IgM antibodies IgM immunoassay immunoassays immunological inactivated nucleic acid nucleic acids other diseases pathogen-specific Patient peptide platform probe Protein RBD reveal Rhesus monkeys SARS-CoV-2 S2 sensitivity Seroconversion seroconversion time Simoa tested Ultrasensitive digital detection. vaccination virus wild-type [DOI] 10.1016/j.bios.2022.114710 PMC 바로가기
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassayArticle Published on 2022-12-012023-07-11 Journal: New Microbiologica [Category] COVID19(2023년), [키워드] COVID-19 Diagnosis immunoassay Laboratory medicine SARS-CoV-2. PMC 바로가기
Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective studyArticle Published on 2022-11-302022-11-15 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome antibodies antibody Blood C-reactive protein carried Cell China CLIA Coronavirus-2 COVID-19 COVID-19 vaccination COVID-19 vaccine decrease described detect distribution dose effective Effectiveness healthy control high-risk population ICV IgG immunization immunoassay immunogenicity immunosuppressive agent inactivated Inactivated vaccine Infection inoculated Logistic regression analysis magnitude methotrexate parameter Patient patients patients treated positive response Prednisolone Prospective Study Protective antibody receiving recruited response to vaccination rheumatic disease Safe Safety Safety. SARS-CoV-2 serious adverse reaction South [DOI] 10.1080/21645515.2022.2090176 PMC 바로가기
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodiesArticle Published on 2022-11-082022-11-15 Journal: Scientific Reports [Category] SARS, 치료기술, [키워드] acute respiratory syndrome administration affecting Analysis analysis anti-RBD IgG antibody anti-SARS-CoV-2 AUC automated binding antibody booster clinical settings Cohort collected Control coronavirus correlation COVID-19 cutoff value demonstrated Effectiveness Genscript gold standard Immunity immunoassay in both groups infected patient Mindray NAb neutralization Neutralization assay neutralization test neutralizing antibody population level protective immunity provide pseudovirus R 2 Rapid receiver operating characteristic Research ROC ROC Curve Sample SARS-CoV-2 SARS-CoV-2 infected patient second dose sensitivity shown significantly specificity subjects sVNT sVNT assay symptoms onset tested threshold vaccinated individual Vaccine virus neutralization test was performed [DOI] 10.1038/s41598-022-21317-x PMC 바로가기
Enhanced Label-Free Nanoplasmonic Cytokine Detection in SARS-CoV-2 Induced Inflammation Using Rationally Designed Peptide AptamerArticle Published on 2022-11-022022-11-15 Journal: ACS applied materials & interfaces [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] acute respiratory syndrome Analysis Antibody-derived peptide aptamer (ADPA) applied aptamer Biomarker coronavirus COVID-19 patients cytokine detection Detection limit Disease progression disorders enhanced IL-6 immune pathway Immune status immunoassay immunoassays in vitro induced Inflammation inflammatory status information interleukin 6 (IL-6 Interluekin-6 (IL-6) Interpretation limit of detection localized surface plasmon resonance (LSPR) magnitude nanoplasmonic immunoassay pandemic pathogenic inflammation Patient peptide Predictive profile Prognosis provide quantification Rapid SARS-CoV-2 serum serum cytokine Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [DOI] 10.1021/acsami.2c14748 PMC 바로가기